New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 14, 2014
06:03 EDTBBBY, SHPGStocks with implied volatility below IV index mean; BBBY SHPG
Stocks with implied volatility below IV index mean; Bed Bath & Beyond (BBBY) 23, Shire (SHPG) 37 according to iVolatility.
News For BBBY;SHPG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
April 9, 2015
13:27 EDTSHPGShire announces FDA Priority Review designation for lifitegrast
Subscribe for More Information
13:09 EDTBBBYOn The Fly: Midday Wrap
Subscribe for More Information
11:14 EDTBBBYHome goods retailers move in opposite directions following Q4 earnings reports
Subscribe for More Information
10:48 EDTSHPGDeutsche compares PTC Therapeutics to Vertex, boosts target by $40
Subscribe for More Information
10:32 EDTBBBYOptions with decreasing implied volatility
Subscribe for More Information
09:18 EDTBBBYBofA/Merrill retail analysts hold an analyst/industry conference call
Subscribe for More Information
05:51 EDTBBBYWells Fargo remains cautious on Bed Bath & Beyond
Subscribe for More Information
05:27 EDTSHPGShire reports results from three placebo-controlled Phase 2 studies of SHP625
Subscribe for More Information
April 8, 2015
19:46 EDTBBBYOn The Fly: After Hours Movers
UP AFTER EARNINGS: Apogee (APOG), up 6.4%... Pier 1 Imports (PIR), up 4.4%. ALSO HIGHER: Inovio Pharmaceuticals (INO), up 5.6% after being selected by DARPA to lead $45M Ebola prevention program. DOWN AFTER EARNINGS: Alcoa (AA), down 3.5%... Bed Bath & Beyond (BBBY), down 3.5%. ALSO LOWER: Zynga (ZNGA), down 10.3% after announcing CEO transition... Memorial Production (MEMP), down 2.9% after filing to sell 4.6M common units owned by MRD Holdco... Regulus (RGLS), down 2.2% after filing to sell 3.3M shares for Isis Pharmaceuticals.
16:19 EDTBBBYBed Bath & Beyond sees FY15 SSS up 2%-3%
Subscribe for More Information
16:18 EDTBBBYBed Bath & Beyond sees Q1 EPS 90c-95c, consensus $1.01
Subscribe for More Information
16:16 EDTBBBYBed Bath & Beyond reports Q4 EPS $1.80, consensus $1.80
Subscribe for More Information
15:24 EDTBBBYNotable companies reporting after market close
Subscribe for More Information
14:45 EDTBBBYBed Bath & Beyond technical comments ahead of earnings
Subscribe for More Information
April 7, 2015
10:10 EDTSHPGJazz patent on Xyrem latest to be challenged by Kyle Bass
Subscribe for More Information
08:14 EDTBBBYBed Bath & Beyond April volatility elevated into Q4 and outlook
Subscribe for More Information
08:10 EDTSHPGShire shares pricing in worst case scenario for patents, says Citigroup
Subscribe for More Information
07:13 EDTSHPGShire patent challenges only modest threat, says Jefferies
Subscribe for More Information
05:23 EDTSHPGShire reaches agreement with FDA on clear regulatory path for SHP465
Shire announces that it has reached an agreement with the FDA on a clear regulatory path for SHP465, an investigational oral stimulant medication being evaluated as a potential treatment for Attention-Deficit/Hyperactivity Disorder, or ADHD, in adults. Shire has agreed with the FDA to conduct a short-term efficacy and safety study in pediatric patients with ADHD. While Shire intends to pursue an adult indication, the FDA is requesting this additional pediatric data to better understand the potential effects of SHP465 on children with ADHD in the event of use in this population. The company anticipates the clinical trial's first patient, first visit to take place in August 2015, with study completion targeted by the last quarter of 2016. Shire then expects to submit to the FDA by 2Q17 a Class 2 resubmission for approval of SHP465 as a treatment for ADHD in adults, which typically entails a 6-month review. Pending FDA approval, Shire anticipates launching the medicine in the second half of 2017. This update follows Shire's announcement on October 9, 2014, that it was engaging the FDA to determine the parameters of clinical data requirements in order to submit the Class 2 resubmission.
April 6, 2015
09:09 EDTSHPGShire says will defend patents 'vigorously' after Hayman petitions
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use